Showing results (1561-1570 of 2,165) with videos related to

Sort By:
Pageof 217
The Canadian Journal of Urology|February 24, 2024
Mullerianosis of the urinary bladder: a case reportGrace Helene Wegrzyn, Melissa Kilianek, Suzanne Iwaz, et al.
The Canadian Journal of Urology|February 24, 2024
Grant funding among underrepresented minority and women urologists at academic institutionsSimon White, David Tella, Bahrom Ostad, et al.
The Canadian Journal of Urology|October 15, 2023
Temporarily implanted nitinol device versus prostatic urethral lift for minimally invasive surgical treatment of benign prostatic hyperplasia with lower urinary tract symptoms: a matching-adjusted indirect comparisonKenneth M Kernen, Shalina Omar, Bradley Goodnight, et al.
The Canadian Journal of Urology|October 15, 2023
Are American transplant centers willing to transplant prisonersLauren S Faber, Tania Lyons, Michael S Davis
The Canadian Journal of Urology|October 15, 2023
Liposomal versus plain bupivacaine for pain control following vaginal reconstructionStephanie Jensen, Akin S Amasyali, Mohamed Keheila, et al.
The Canadian Journal of Urology|March 9, 2026
Case report: minimally invasive management of two major complications of colonic perforation and pseudoaneurysm formation following nephrostomy tube placementMarie-Lou Letouche, Aideen Madden, Mariela Corralles, et al.
The Canadian Journal of Urology|October 27, 2024
Implications of MRI contrast enhancement following focal prostate cancer cryoablationJames Wysock, Jesse Persily, Angela Tong, et al.
The Canadian Journal of Urology|October 27, 2024
Side effect management algorithms for niraparib/abiraterone acetate in prostate cancerJean-Baptiste Lattouf, Jenny J Ko, Margot K Davis, et al.
The Canadian Journal of Urology|October 27, 2024
Prehabilitation in patients undergoing bladder cancer surgery - A systematic review and meta-analysisDaniel Steffens, Cherry Koh, Nicholas Hirst, et al.
The Canadian Journal of Urology|March 9, 2026
PSMA PET/CT-guided pelvic lymph node dissection in patients with unfavorable intermediate- or high-risk prostate cancerEva Donck, Sofie Verbeke, Pieter De Visschere, et al.
Pageof 217